Post-Approval Drug Failures: More Reasons To Eliminate P-values & Parameter-Centric Methods
Some comments on the JAMA: Internal Medicine article “An International Perspective on Drugs for Cancer: The Best of Times, the Worst of Times” by Richard Lehman. Drugs increase fast, an…
